Mycoplasma pneumonae organisms possessing a hemadsorbing-negative (HA-) phenotype comprise more than 50% of the population of virulent M. pneumoniae cultures. Monoclonal antibody to P1, the major adhesin of M. pneumoniae reacts with this HA-mycoplasma fraction based upon radioimmunoprecipitation and immunoblotting. Demonstration of P1 in the entire mycoplasma population suggests that topological organization of this adhesin in the membrane or the physiological state of the mycoplasmas may determine hemadsorbing capabilities.
The adherence of Mycoplasma pneurnoniae to host cell membranes appears to be mediated by a protein adhesin designated P1 (3, (7) (8) (9) (10) . This membrane protein is surface localized and trypsin sensitive (3, 5, 7, 8) . The absence of P1 and other specific proteins of M. pneumoniae as determined by mutant analysis (11) and chemical and immunological characterization (9, 10 ) is related to loss of hemadsorption capabilities. When virulent, hemadsorbing-positive (HA') M. pneumoniae was grown in broth culture and tested for adherence capacity, only a subpopulation (varying from 7 to 30%) of the M. pneurnoniae culture cytadsorbed (1, 2) . We initiated experiments to determine whether the hemadsorbing-negative (HA-) population was deficient in P1.
Virulent HA' M. pneumoniae parent strain M129-B25C
was grown in 32-oz (-1-liter) glass bottles containing 70 ml of Hayflick medium (6) . After 72 h the medium was changed, fresh medium (prewarmed to 37°C) was added, and cultures were incubated for an additional 24 h. Mycoplasmas were metabolically labeled with [35S]methionine (250 uCi) for 90 min, followed by a 30-min chase in fresh unlabeled medium (10) . Glass-attached M. pneumoniae organisms were scraped into 10 ml of phosphate-buffered saline, centrifuged for 10 min at 12,000 x g at 4°C, suspended in buffer, and used directly in the hemadsorption assay (10) . To remove the HA' mycoplasmas, M. pneumoniae organisms (1.5 ml of a suspension of 0.2 mg of mycoplasma protein per ml) were incubated with erythrocyte (RBC) suspensions (1 ml of a 10% suspension) of human 0 blood type or sheep cells for 30 mim at 37°C. The mycoplasma-RBC mixture was centrifuged for 10 min at 300 x g, and the supernatant (which included the HA-mycoplasmas) was reincubated with two additional RBC preparations as outlined above. Mycoplasmas which remained in the supernatant after the third RBC adsorption were collected by centrifugation (12,000 x g, 20 min at 4°C). The resultant mycoplasma pellet was solubilized and tested in the soluble antigen radioimmunoprecipitation assay as previously described (14), using a monoclonal antibody (immunoglobulin G) to protein P1 (13 coplasma fraction (Fig. 1, lanes a and b) are essentially identical to that of the original mycoplasma suspension (Fig.  1, lane c) . Protein P1 was detected in each profile. Electroblotting of the proteins to nitrocellulose filters (15) and detection of P1 with the anti-Pl monoclonal antibody reinforced the identity of P1. Confirmation of protein P1 in the HA-mycoplasmas was also established by performing a soluble radioimmunoprecipitation test (Fig. 2) with anti-Pl monoclonal antibody.
M. pneumoniae protein P1 is the major adhesin of M. pneumoniae. This protein is densely clustered at the tip region of virulent M. pneumoniae, mediating adherence of mycoplasmas to host cells (3, 5, 8) . It has also been shown that P1 is distributed in less-dense foci along the M. pneumoniae unit membrane (3) . Further experiments are warranted to elucidate the distribution pattern of P1 on the membranes of the HA-fraction of virulent M. pneumoniae populations.
